A trial comparing NNC0123-0000-0338 in a tablet formulation and insulin glargine in subjects with type 2 diabetes currently treated with oral antidiabetic therapy

Mise à jour : Il y a 4 ans
Référence : U1111-1158-3620

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To compare the glycaemic control after 8 weeks of treatment with oral insulin 338 in a GIPET® I tablet formulation versus subcutaneous insulin glargine, when both are administered once daily in combination with metformin ± DPP-4 inhibitor in subjects with type 2 diabetes inadequately controlled on oral antidiabetic therapy


Critère d'inclusion

  • Diabetes Mellitus, Type 2

Liens